Hand; Management; Osteoarthritis; Patient-centered; Treatment guideline; Geriatrics and Gerontology; Aging
Abstract :
[en] Hand osteoarthritis is the most common joint condition and is associated with significant morbidity. It is of paramount importance that patients are thoroughly assessed and examined when complaining of hand stiffness, pain, deformity or disability and that the patient's concerns and expectations are addressed by the healthcare professional. In 2019 the American College of Rheumatology and Arthritis Foundation (ACR/AF) produced guidelines which included recommendations for the treatment of hand osteoarthritis. An ESCEO expert working group (including patients) was convened and composed this paper with the aim to assess whether these guidelines were appropriate for the treatment of hand osteoarthritis therapy in Europe and whether they met with the ESCEO patient-centered approach. Indeed, patients are the key stakeholders in healthcare and eliciting the patient's preference is vital in the context of an individual consultation but also for informing research and policy-making. The patients involved in this working group emphasised the often-neglected area of aesthetic changes in hand osteoarthritis, importance of developing pharmacological therapies which can alleviate pain and disability and the need of the freedom to choose which approach (out of pharmacological, surgical or non-pharmacological) they wished to pursue. Following robust appraisal, it was recommended that the ACR/AF guidelines were suitable for a European context (as described within the body of the manuscript) and it was emphasised that patient preferences are key to the success of individual consultations, future research and future policy-making.
Disciplines :
Rheumatology
Author, co-author :
Fuggle, Nicholas; MRC Lifecourse Epidemiology Centre, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK
Bere, Nathalie; European Medicines Agency, Amsterdam, The Netherlands
Bruyère, Olivier ; Centre Hospitalier Universitaire de Liège - CHU > > Service de médecine de l'appareil locomoteur
Rosa, Mario Manuel; Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal
Prieto Yerro, María Concepción; Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain
Dennison, Elaine; MRC Lifecourse Epidemiology Centre, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK
Dincer, Fitnat; Department of Physical and Rehabilitation Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey
Gabay, Cem; Division of Rheumatology, University Hospital of Geneva, and Department of Pathology and Immunology, University of Geneva of Medicine, Geneva, Switzerland
Haugen, Ida K; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway
Herrero-Beaumont, Gabriel; Head of Rheumatology Department, Bone and Joint Research Unit, IIS-Fundación Jiménez Díaz UAM, 28040, Madrid, Spain
Hiligsmann, Mickaël ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé ; Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, 6200 MD, Maastricht, The Netherlands
Hochberg, Marc C; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA
Laslop, Andrea; Scientific Office, Federal Office for Safety in Health Care, Vienna, Austria
Matijevic, Radmila; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia ; Clinical Center of Vojvodina, Clinic for Orthopedic Surgery, Novi Sad, Serbia
Maheu, Emmanuel; Rheumatology Department, Hospital Saint-Antoine, AP-HP, and Private Office, Paris, France
Migliore, Alberto; Rheumatology Unit - San Pietro Fatebenefratelli Hospital, Rome, Italy
Pelletier, Jean-Pierre; Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM) and Arthritis Division, University of Montreal Hospital Centre (CHUM), Montreal, Canada
Radermecker, Régis ; Centre Hospitalier Universitaire de Liège - CHU > > Service de diabétologie, nutrition, maladies métaboliques
Rannou, François; Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis, Hôpitaux Universitaires-Paris Centre, Groupe Hospitalier Cochin, Assistance Publique-Hôpitaux de Paris, Université de Paris, INSERM U1124, Paris, France
Uebelhart, Brigitte; Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland
Uebelhart, Daniel; Division of Musculoskeletal, Internal Medicine and Oncological Rehabilitation, Leukerbad Clinic -Private Rehabilitation Clinic, 3954, Leukerbad, Switzerland
Veronese, Nicola; Department of Internal Medicine, Geriatrics Section, University of Palermo, Palermo, Italy
Vlaskovska, Mila; Medical Faculty, Department of Pharmacology and Toxicology, Medical University Sofia, Sofia, Bulgaria
Rizzoli, René; Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland
Mobasheri, Ali; Division of Public Health, Epidemiology and Health Economics, WHO Collaborating Center for Public Health Aspects of Musculo-Skeletal Health and Ageing, University of Liège, Avenue Hippocrate 13, CHU B23, 4000, Liege, Belgium ; Research Unit of Medical Imaging, Physics and Technology, Faculty of Medicine, University of Oulu, 90014, Oulu, Finland ; Department of Regenerative Medicine, State Research Institute Centre for Innovative Medicine, 08406, Vilnius, Lithuania ; Departments of Orthopedics, Rheumatology and Clinical Immunology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands ; Department of Joint Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China
Cooper, Cyrus ; MRC Lifecourse Epidemiology Centre, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK. cc@mrc.soton.ac.uk
Reginster, Jean-Yves; Division of Public Health, Epidemiology and Health Economics, WHO Collaborating Center for Public Health Aspects of Musculo-Skeletal Health and Ageing, University of Liège, Avenue Hippocrate 13, CHU B23, 4000, Liege, Belgium
Haugen IK, Englund M, Aliabadi P et al (2011) Prevalence, incidence and progression of hand osteoarthritis in the general population: the Framingham Osteoarthritis Study. Ann Rheum Dis 70:1581–1586. 10.1136/ard.2011.150078 DOI: 10.1136/ard.2011.150078
Kwok WY, Kloppenburg M, Marshall M et al (2013) Comparison of clinical burden between patients with erosive hand osteoarthritis and inflammatory arthritis in symptomatic community-dwelling adults: the Keele clinical assessment studies. Rheumatology (Oxford). 52:2260–2267. 10.1093/rheumatology/ket267 DOI: 10.1093/rheumatology/ket267
Kwok WY, Kloppenburg M, Rosendaal FR et al (2011) Erosive hand osteoarthritis: its prevalence and clinical impact in the general population and symptomatic hand osteoarthritis. Ann Rheum Dis 70:1238–1242. 10.1136/ard.2010.143016 DOI: 10.1136/ard.2010.143016
Pereira D, Peleteiro B, Araújo J et al (2011) The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage 19:1270–1285. 10.1016/j.joca.2011.08.009 DOI: 10.1016/j.joca.2011.08.009
Worldometer (2021). https://www.worldometers.info. Accessed Jan 2022
United Nations WB. Population projections (2022). https://data.worldbank.org/indicator/SP.POP.GROW. Accessed Jan 2022
Turkiewicz A, Petersson IF, Björk J et al (2014) Current and future impact of osteoarthritis on health care: a population-based study with projections to year 2032. Osteoarthritis Cartilage 22:1826–1832. 10.1016/j.joca.2014.07.015 DOI: 10.1016/j.joca.2014.07.015
Kloppenburg M, Kroon FP, Blanco FJ et al (2019) 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis 78:16–24. 10.1136/annrheumdis-2018-213826 DOI: 10.1136/annrheumdis-2018-213826
Kolasinski SL, Neogi T, Hochberg MC et al (2020) 2019 American college of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 72:149–162. 10.1002/acr.24131 DOI: 10.1002/acr.24131
Bannuru RR, Osani MC, Vaysbrot EE et al (2019) OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 27:1578–1589. 10.1016/j.joca.2019.06.011 DOI: 10.1016/j.joca.2019.06.011
Marshall M, Watt FE, Vincent TL et al (2018) Hand osteoarthritis: clinical phenotypes, molecular mechanisms and disease management. Nat Rev Rheumatol 14:641–656. 10.1038/s41584-018-0095-4 DOI: 10.1038/s41584-018-0095-4
Mobasheri A, Batt M (2016) An update on the pathophysiology of osteoarthritis. Ann Phys Rehabil Med 59:333–339. 10.1016/j.rehab.2016.07.004 DOI: 10.1016/j.rehab.2016.07.004
Courties A, Sellam J, Maheu E et al (2017) Coronary heart disease is associated with a worse clinical outcome of hand osteoarthritis: a cross-sectional and longitudinal study. RMD Open 3:e000344. 10.1136/rmdopen-2016-000344 DOI: 10.1136/rmdopen-2016-000344
Hodkinson B, Maheu E, Michon M et al (2012) Assessment and determinants of aesthetic discomfort in hand osteoarthritis. Ann Rheum Dis 71:45–49. 10.1136/ard.2011.153965 DOI: 10.1136/ard.2011.153965
Deveza LA, Nelson AE, Loeser RF (2019) Phenotypes of osteoarthritis: current state and future implications. Clin Exp Rheumatol 37:64–72
Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502. 10.1136/ard.16.4.494 DOI: 10.1136/ard.16.4.494
Haugen IK, Mathiessen A, Slatkowsky-Christensen B et al (2016) Synovitis and radiographic progression in non-erosive and erosive hand osteoarthritis: is erosive hand osteoarthritis a separate inflammatory phenotype? Osteoarthritis Cartilage. 24:647–654. 10.1016/j.joca.2015.11.014 DOI: 10.1016/j.joca.2015.11.014
Wittoek R, Cruyssen BV, Verbruggen G (2012) Predictors of functional impairment and pain in erosive osteoarthritis of the interphalangeal joints: comparison with controlled inflammatory arthritis. Arthritis Rheum 64:1430–1436. 10.1002/art.33502 DOI: 10.1002/art.33502
Keen HI, Lavie F, Wakefield RJ et al (2008) The development of a preliminary ultrasonographic scoring system for features of hand osteoarthritis. Ann Rheum Dis 67:651–655. 10.1136/ard.2007.077081 DOI: 10.1136/ard.2007.077081
Kaufmann RA, Lögters TT, Verbruggen G et al (2010) Osteoarthritis of the distal interphalangeal joint. J Hand Surg 35:2117–2125. 10.1016/j.jhsa.2010.09.003 DOI: 10.1016/j.jhsa.2010.09.003
de Wit M, Cooper C, Tugwell P et al (2019) Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clin Exp Res 31:905–915. 10.1007/s40520-019-01193-8 DOI: 10.1007/s40520-019-01193-8
PREFER. Patient preferences (Innovative Medicines Initiative). https://www.imi-prefer.eu/. Accessed Jan 2022
Hiligsmann M, Dennison E, Beaudart C et al (2020) A discrete-choice experiment to assess patients’ preferences for osteoarthritis treatment: an ESCEO working group. Semin Arthritis Rheum 50:859–866. 10.1016/j.semarthrit.2020.08.005 DOI: 10.1016/j.semarthrit.2020.08.005
Arslan IG, Huls SPI, de Bekker-Grob EW et al (2020) Patients’, healthcare providers’, and insurance company employees’ preferences for knee and hip osteoarthritis care: a discrete choice experiment. Osteoarthritis Cartilage 28:1316–1324. 10.1016/j.joca.2020.07.002 DOI: 10.1016/j.joca.2020.07.002
Turk D, Boeri M, Abraham L et al (2020) Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment. Osteoarthritis Cartilage 28:1202–1213. 10.1016/j.joca.2020.06.006 DOI: 10.1016/j.joca.2020.06.006
Harris CA, Shauver MJ, Yuan F et al (2018) understanding patient preferences in proximal interphalangeal joint surgery for osteoarthritis: a conjoint analysis. J Hand Surg Am 43:615-624.e614. 10.1016/j.jhsa.2018.03.001 DOI: 10.1016/j.jhsa.2018.03.001
van Overbeeke E, Janssens R, Whichello C et al (2019) Design, conduct, and use of patient preference studies in the medical product life cycle: a multi-method study. Front Pharmacol. 10.3389/fphar.2019.01395 DOI: 10.3389/fphar.2019.01395
de Wit M, Cooper C, Reginster JY (2019) Practical guidance for patient-centred health research. Lancet 393:1095–1096. 10.1016/s0140-6736(19)30034-0 DOI: 10.1016/s0140-6736(19)30034-0
Bruyère O, Honvo G, Veronese N et al (2019) An updated algorithm recommendation for the management of knee osteoarthritis from the european society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Semin Arthritis Rheum 49:337–350. 10.1016/j.semarthrit.2019.04.008 DOI: 10.1016/j.semarthrit.2019.04.008
Zhang Z, Huang C, Cao Y et al (2021) revised algorithm for the management of knee osteoarthritis-the Chinese viewpoint. Aging Clin Exp Res 33:2141–2147. 10.1007/s40520-021-01906-y DOI: 10.1007/s40520-021-01906-y
Yeap SS, Tanavalee A, Perez EC et al (2021) 2019 revised algorithm for the management of knee osteoarthritis: the Southeast Asian viewpoint. Aging Clin Exp Res 33:1149–1156. 10.1007/s40520-021-01834-x DOI: 10.1007/s40520-021-01834-x
Kroon FPB, Carmona L, Schoones JW et al (2018) Efficacy and safety of non-pharmacological, pharmacological and surgical treatment for hand osteoarthritis: a systematic literature review informing the 2018 update of the EULAR recommendations for the management of hand osteoarthritis. RMD Open. 4:e000734. 10.1136/rmdopen-2018-000734 DOI: 10.1136/rmdopen-2018-000734
Altman R, Alarcón G, Appelrouth D et al (1990) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 33:1601–1610. 10.1002/art.1780331101 DOI: 10.1002/art.1780331101
Cadet C, Maheu E (2021) Non-steroidal anti-inflammatory drugs in the pharmacological management of osteoarthritis in the very old: prescribe or proscribe? Ther Adv Musculoskelet Dis. 10.1177/1759720x211022149 DOI: 10.1177/1759720x211022149
Bhala N, Emberson J, Merhi A et al (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 382:769–779. 10.1016/s0140-6736(13)60900-9 DOI: 10.1016/s0140-6736(13)60900-9
Wang X, Tian HJ, Yang HK et al (2011) Meta-analysis: cyclooxygenase-2 inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis. Eur J Gastroenterol Hepatol 23:876–880. 10.1097/MEG.0b013e328349de81 DOI: 10.1097/MEG.0b013e328349de81
Gunter BR, Butler KA, Wallace RL et al (2017) Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis. J Clin Pharm Ther 42:27–38. 10.1111/jcpt.12484 DOI: 10.1111/jcpt.12484
Nissen SE, Yeomans ND, Solomon DH et al (2016) Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 375:2519–2529. 10.1056/NEJMoa1611593 DOI: 10.1056/NEJMoa1611593
Curtis E, Fuggle N, Shaw S et al (2019) Safety of cyclooxygenase-2 inhibitors in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs Aging 36:25–44. 10.1007/s40266-019-00664-x DOI: 10.1007/s40266-019-00664-x
Honvo G, Leclercq V, Geerinck A et al (2019) Safety of topical non-steroidal anti-inflammatory drugs in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs Aging 36:45–64. 10.1007/s40266-019-00661-0 DOI: 10.1007/s40266-019-00661-0
Zhang W, Jones A, Doherty M (2004) Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis 63:901–907. 10.1136/ard.2003.018531 DOI: 10.1136/ard.2003.018531
Zhang W, Nuki G, Moskowitz RW et al (2010) OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 18:476–499. 10.1016/j.joca.2010.01.013 DOI: 10.1016/j.joca.2010.01.013
Roberts E, Delgado Nunes V, Buckner S et al (2016) Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis 75:552–559. 10.1136/annrheumdis-2014-206914 DOI: 10.1136/annrheumdis-2014-206914
Bartels EM, Bliddal H, Schøndorff PK et al (2010) Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage 18:289–296. 10.1016/j.joca.2009.10.006 DOI: 10.1016/j.joca.2009.10.006
Towheed TE, Anastassiades T (2007) Glucosamine therapy for osteoarthritis: an update. J Rheumatol 34:1787–1790
Singh JA, Noorbaloochi S, MacDonald R et al (2015) Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 10.1002/14651858.CD005614.pub2 DOI: 10.1002/14651858.CD005614.pub2
Reginster JY, Bruyere O, Neuprez A (2007) Current role of glucosamine in the treatment of osteoarthritis. Rheumatology (Oxford) 46:731–735. 10.1093/rheumatology/kem026 DOI: 10.1093/rheumatology/kem026
Eriksen P, Bartels EM, Altman RD et al (2014) Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials. Arthritis Care Res (Hoboken) 66:1844–1855. 10.1002/acr.22376 DOI: 10.1002/acr.22376
Hochberg MC (2010) Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Osteoarthritis Cartilage 18:S28-31. 10.1016/j.joca.2010.02.016 DOI: 10.1016/j.joca.2010.02.016
Honvo G, Reginster JY, Rabenda V et al (2019) Safety of symptomatic slow-acting drugs for osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs Aging. 36:65–99. 10.1007/s40266-019-00662-z DOI: 10.1007/s40266-019-00662-z
Tenti S, Giordano N, Mondanelli N et al (2020) A retrospective observational study of glucosamine sulfate in addition to conventional therapy in hand osteoarthritis patients compared to conventional treatment alone. Aging Clin Exp Res 32:1161–1172. 10.1007/s40520-019-01305-4 DOI: 10.1007/s40520-019-01305-4
Shin K, Kim JW, Moon KW et al (2013) The efficacy of diacerein in hand osteoarthritis: a double-blind, randomized, placebo-controlled study. Clin Ther 35:431–439. 10.1016/j.clinthera.2013.02.009 DOI: 10.1016/j.clinthera.2013.02.009
Arden NK, Perry TA, Bannuru RR et al (2021) Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines. Nat Rev Rheumatol 17:59–66. 10.1038/s41584-020-00523-9 DOI: 10.1038/s41584-020-00523-9
Reginster JY, Veronese N (2021) Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment. Aging Clin Exp Res 33:37–47. 10.1007/s40520-020-01643-8 DOI: 10.1007/s40520-020-01643-8
Verbruggen G, Goemaere S, Veys EM (2002) Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. Clin Rheumatol 21:231–243. 10.1007/s10067-002-8290-7 DOI: 10.1007/s10067-002-8290-7
Gabay C, Medinger-Sadowski C, Gascon D et al (2011) Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center. Arthritis Rheum 63:3383–3391. 10.1002/art.30574 DOI: 10.1002/art.30574
Honvo G, Lengelé L, Charles A et al (2020) Role of collagen derivatives in osteoarthritis and cartilage repair: a systematic scoping review with evidence mapping. Rheumatol Ther 7:703–740. 10.1007/s40744-020-00240-5 DOI: 10.1007/s40744-020-00240-5
Bartoloni E, Luccioli F, La Paglia GMC et al (2019) Effect of Sinovial High-Low® injections in trapeziometacarpal osteoarthritis. Clin Exp Rheumatol 37:166
Tenti S, Cheleschi S, Mondanelli N et al (2021) New trends in injection-based therapy for thumb-base osteoarthritis: where are we and where are we going? Front Pharmacol. 10.3389/fphar.2021.637904 DOI: 10.3389/fphar.2021.637904
Rocchi L, Merolli A, Giordani L et al (2017) Trapeziometacarpal joint osteoarthritis: a prospective trial on two widespread conservative therapies. Muscles Ligaments Tendons J 7:603–610. 10.11138/mltj/2017.7.4.603 DOI: 10.11138/mltj/2017.7.4.603
Khan M, Waseem M, Raza A et al (2009) Quantitative assessment of improvement with single corticosteroid injection in thumb cmc joint osteoarthritis? Open Orthop J 3:48–51. 10.2174/1874325000903010048 DOI: 10.2174/1874325000903010048
Østerås N, Kjeken I, Smedslund G et al (2017) Exercise for hand osteoarthritis: a cochrane systematic review. J Rheumatol 44:1850–1858. 10.3899/jrheum.170424 DOI: 10.3899/jrheum.170424
Biver E, Berenbaum F, Valdes AM et al (2019) Gut microbiota and osteoarthritis management: an expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Ageing Res Rev 55:100946. 10.1016/j.arr.2019.100946 DOI: 10.1016/j.arr.2019.100946
Slatkowsky-Christensen B, Mowinckel P, Kvien TK (2009) Health status and perception of pain: a comparative study between female patients with hand osteoarthritis and rheumatoid arthritis. Scand J Rheumatol 38:342–348. 10.1080/03009740902913496 DOI: 10.1080/03009740902913496
Kloppenburg M, Peterfy C, Haugen IK et al (2019) Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis. Ann Rheum Dis 78:413–420. 10.1136/annrheumdis-2018-213336 DOI: 10.1136/annrheumdis-2018-213336
Kloppenburg M, Ramonda R, Bobacz K et al (2018) Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial. Ann Rheum Dis 77:1757–1764. 10.1136/annrheumdis-2018-213202 DOI: 10.1136/annrheumdis-2018-213202
Schett G, Bainbridge C, Berkowitz M et al (2020) Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial. Lancet Rheumatol 2:e623–e632. 10.1016/S2665-9913(20)30171-5 DOI: 10.1016/S2665-9913(20)30171-5
Aitken D, Laslett LL, Pan F et al (2018) A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand osteoarthritis - the HUMOR trial. Osteoarthritis Cartilage 26:880–887. 10.1016/j.joca.2018.02.899 DOI: 10.1016/j.joca.2018.02.899
Chevalier X, Ravaud P, Maheu E et al (2015) Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial. Ann Rheum Dis 74:1697–1705. 10.1136/annrheumdis-2014-205348 DOI: 10.1136/annrheumdis-2014-205348
Richette P, Latourte A, Sellam J et al (2020) Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial. Ann Rheum Dis. 10.1136/annrheumdis-2020-218547 DOI: 10.1136/annrheumdis-2020-218547
Kedor C, Detert J, Rau R et al (2021) Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. RMD Open. 10.1136/rmdopen-2021-001660 DOI: 10.1136/rmdopen-2021-001660
Kingsbury SR, Tharmanathan P, Keding A et al (2018) Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis: a randomized trial. Ann Intern Med 168:385–395. 10.7326/m17-1430 DOI: 10.7326/m17-1430
Lee W, Ruijgrok L, Boxma-de Klerk B et al (2018) Efficacy of hydroxychloroquine in hand osteoarthritis: a randomized, double-blind placebo-controlled trial. Arthritis Care Res (Hoboken) 70:1320–1325. 10.1002/acr.23471 DOI: 10.1002/acr.23471
Davis CR, Ruediger CD, Dyer KA et al (2021) Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH). Osteoarthritis Cartilage 29:208–214. 10.1016/j.joca.2020.11.002 DOI: 10.1016/j.joca.2020.11.002
Ferrero S, Wittoek R, Allado E et al (2021) Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial. Semin Arthritis Rheum 51:831–838. 10.1016/j.semarthrit.2021.04.016 DOI: 10.1016/j.semarthrit.2021.04.016
Kroon FPB, Kortekaas MC, Boonen A et al (2019) Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial. Lancet 394:1993–2001. 10.1016/s0140-6736(19)32489-4 DOI: 10.1016/s0140-6736(19)32489-4
Park JK, Shin K, Kang EH et al (2016) Efficacy and tolerability of GCSB-5 for hand osteoarthritis: a randomized. Controlled Trial Clin Ther 38:1858-1868.e1852. 10.1016/j.clinthera.2016.06.016 DOI: 10.1016/j.clinthera.2016.06.016
Fuggle NR, Cooper C, Oreffo ROC et al (2020) Alternative and complementary therapies in osteoarthritis and cartilage repair. Aging Clin Exp Res 32:547–560. 10.1007/s40520-020-01515-1 DOI: 10.1007/s40520-020-01515-1
